Log In
Print
BCIQ
Print
Print this Print this
 

CNV2197944

  Manage Alerts
Collapse Summary General Information
Company Calchan Ltd.
DescriptionState-dependent calcium channel inhibitor
Molecular Target Calcium channel ; Calcium channel voltage-dependent N type alpha 1B subunit (CACNA1B) (CaV2.2)
Mechanism of ActionCalcium channel blocker; N-type (Cav2.2) calcium channel modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat neuropathic and inflammatory pain; Treat pain associated with diabetic peripheral neuropathy (DPN); Treat post-herpetic neuralgia (PHN)
Regulatory Designation

Partner

Convergence Pharmaceuticals Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today